{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:59:38Z","timestamp":1790179178366,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.exer.2011.09.010","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T02:15:22Z","timestamp":1317262522000},"page":"761-766","source":"Crossref","is-referenced-by-count":53,"title":["Comparison of choroidal and retinal endothelial cells: Characteristics and response to VEGF isoforms and anti-VEGF treatments"],"prefix":"10.1016","volume":"93","author":[{"given":"Elizabeth A.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindi J.","family":"Samaranayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hopkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried M.","family":"Amoaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2011.09.010_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate","volume":"114","author":"Adamis","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib2","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1097\/01.CCM.0000057847.32590.C1","article-title":"Endothelial cell heterogeneity","volume":"31","author":"Aird","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.exer.2011.09.010_bib3","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1073\/pnas.082110999","article-title":"A\u00a0dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus","volume":"99","author":"Ancelin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.exer.2011.09.010_bib4","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2011.09.010_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/02713683.2010.489727","article-title":"Influence of non-toxic doses of bevacizumab and ranibizumab on endothelial functions and inhibition of angiogenesis","volume":"35","author":"Barzelay","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2011.09.010_bib6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2006.098426","article-title":"Vascular endothelial growth factor biology: clinical implications for ocular treatments","volume":"90","author":"Bhisitkul","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2011.09.010_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bjo.2007.127670","article-title":"The effects of growth factors on the proliferation and in\u00a0vitro angiogenesis of human macular inner choroidal endothelial cells","volume":"92","author":"Browning","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjo.2004.063602","article-title":"Isolation, culture, and characterisation of human macular inner choroidal microvascular endothelial cells","volume":"89","author":"Browning","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib39","unstructured":"Browning, A.C., Halligan, E.P., Stewart, E.A., Swan, D.C., Samaranayake, G.J., Amoaku, W.M. Comparative gene expression profiling of HUVEC and ocular vascular endothelial cells. Br. J. Ophthalmol., in press."},{"key":"10.1016\/j.exer.2011.09.010_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0014-4835(03)00219-7","article-title":"Differences between retinal and choroidal microvascular endothelial cells (MVECs) under normal and hypoxic conditions","volume":"77","author":"Brylla","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2011.09.010_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1167\/iovs.05-1494","article-title":"Ocular versus extraocular neovascularization: mirror images or vague resemblances","volume":"47","author":"Campochiaro","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.09.010_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.exer.2008.11.011","article-title":"Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells","volume":"88","author":"Carneiro","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2011.09.010_bib13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/jcb.22378","article-title":"Bevacizumab and ranibizumab on microvascular endothelial cells: a comparative study","volume":"108","author":"Costa","year":"2009","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.exer.2011.09.010_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/mvre.1997.2045","article-title":"Endothelial cells from diverse tissues exhibit differences in growth and morphology","volume":"55","author":"Craig","year":"1998","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.exer.2011.09.010_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.preteyeres.2003.08.001","article-title":"Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition","volume":"22","author":"Das","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2011.09.010_bib16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1242\/jcs.017897","article-title":"The role of adherens junctions and VE-cadherin in the control of vascular permeability","volume":"121","author":"Dejana","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.exer.2011.09.010_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/92.2.241","article-title":"The complexity of endothelial cells. A review","volume":"92","author":"Fajardo","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.exer.2011.09.010_bib18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib19","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1021\/pr050425q","article-title":"Proteomic analysis of amniotic membrane prepared for human transplantation: characterization of proteins and clinical implications","volume":"5","author":"Hopkinson","year":"2006","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.exer.2011.09.010_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/molehr\/4.6.603","article-title":"The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol","volume":"4","author":"Huang","year":"1998","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.exer.2011.09.010_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/jsre.2001.6165","article-title":"Heterotypic smooth muscle cell\/endothelial cell interactions differ between species","volume":"98","author":"Imegwu","year":"2001","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.exer.2011.09.010_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1084\/jem.20022027","article-title":"VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization","volume":"198","author":"Ishida","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.exer.2011.09.010_bib23","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1074\/jbc.271.13.7788","article-title":"The carboxyl-terminal domain (111\u2013165) of vascular endothelial growth factor is critical for its mitogenic potency","volume":"271","author":"Keyt","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2011.09.010_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.exer.2007.05.008","article-title":"Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in\u00a0vitro and in\u00a0vivo","volume":"85","author":"Lowe","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2011.09.010_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2011.09.010_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/exmp.2002.2424","article-title":"Expression of the endothelial markers PECAM-1, vWf, and CD34 in\u00a0vivo and in\u00a0vitro","volume":"72","author":"Muller","year":"2002","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.exer.2011.09.010_bib27","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","article-title":"Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization","volume":"44","author":"Rakic","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.09.010_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.exer.2011.09.010_bib29","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1167\/iovs.05-1229","article-title":"VEGF expression and receptor activation in the choroid during development and in the adult","volume":"47","author":"Saint-Geniez","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.09.010_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.preteyeres.2007.03.002","article-title":"Management of neovascular age-related macular degeneration","volume":"26","author":"Schmidt-Erfurth","year":"2007","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2011.09.010_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","article-title":"Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor","volume":"92","author":"Soker","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exer.2011.09.010_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-007-0568-7","article-title":"Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells","author":"Spitzer","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2011.02.045","article-title":"A\u00a0phase 2\/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema","volume":"118","author":"Sultan","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2011.09.010_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1167\/iovs.03-0106","article-title":"VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2","volume":"45","author":"Usui","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.09.010_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2009.08.005","article-title":"Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion","volume":"149","author":"Wroblewski","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2011.09.010_bib36","doi-asserted-by":"crossref","first-page":"35172","DOI":"10.1074\/jbc.274.49.35172","article-title":"Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis","volume":"274","author":"Yonekura","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2011.09.010_bib37","first-page":"2058","article-title":"Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin","volume":"13","author":"Zamora","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2011.09.010_bib38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483511002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483511002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T02:21:41Z","timestamp":1638930101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483511002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0014483511002727"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2011.09.010","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}